Prediction of efficacy for conversion from adjunctive therapy to monotherapy with eslicarbazepine acetate 800 mg once daily for partial-onset epilepsy
Clinical Pharmacology: Advances and Applications | Aug 15, 2017
Intravenous immunoglobulin for maintenance treatment of chronic inflammatory demyelinating polyneuropathy: A multicentre, open-label, 52-week phase III trial
Journal of Neurology, Neurosurgery & Psychiatry | Aug 15, 2017
Oral Chinese herbal medicine as an adjuvant treatment for chemotherapy, or radiotherapy, induced myelosuppression: A systematic review and meta-analysis of randomized controlled trials
Evidence-based Complementary and Alternative Medicine | Aug 15, 2017